Search Results for "Escitalopram For Dysthymia"
Original Source: Escitalopram in the Treatment of Dysthymic Disorder, Double Blind
This is a 12-week double-blind placebo-controlled study of Escitalopram in treatment of dysthymic Disorder (low-grade chronic depression), with a 12 week open-label extension phase. It is hypothesized that Escitalopram will be superior to placebo in improving depression, as well as psychosocial, temperamental, and cognitive functioning.
Matching Channels
Matching News
Menopause Symptoms May Return After Escitalopram Stopped
Hot flashes and night sweats can return after women stop using escitalopram - an antidepressant - to treat these menopause symptoms, according to a study published online this month in Menopause, the...
Forest Labs cuts FY 2013 earnings forecasts on Lexapro woes
Following the expiration of US drugmaker Forest Laboratories' (NYSE: FRX) once best-selling anxiety drug Lexapro's (escitalopram) patent exclusivity in March 2012, the company says rapidly evolving an...
Antidepressant Escitalopram Helps Heart Problem Caused By Stress
Researchers at Duke Medicine have revealed that a commonly prescribed antidepressant - escitalopram (Lexapro) - could be used to treat a heart condition caused by stress among people suffering from st...
Dysthymia: Coping with long-term depression
Dysthymia — Comprehensive overview covers symptoms, causes and treatment of this type of depression.
ImportanceMental stress can induce myocardial ischemia and also has been implicated in triggering cardiac events. However, pharmacological interventions aimed at reducing mental stress–induced myoca...
CBT preferred over drug therapy for social anxiety disorder
Adults with social anxiety disorder should only be offered pharmacological treatment (escitalopram or sertraline) once the option of cognitive behavioural therapy (CBT) has been offered, explored and...
First Person: Dysthymia Is a Hidden Depression
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) will be released in May. Yahoo is featuring first-person stories from Americans who are diagnosed with some of th...
Matching PubMed Articles
Despite the clinical prevalence of the antidepressant escitalopram, over 30% of escitalopram-treated patients fail to respond to treatment. Recent gene association studies have highlighted a potential...
The aim of this proof-of-concept study was to compare the efficacy of escitalopram (20 mg/d) in combination with fixed doses of gaboxadol to escitalopram (20 mg) in the treatment of patients with seve...
Inflammation may contribute to the pathogenesis of depression and antidepressants are hypothesised to have an anti-inflammatory effect. In this randomised double-blinded trial we investigated the cyto...
ABSTRACTBackground: Antipsychotics are frequently used to treat psychosis, aggression and agitation in patients with Alzheimer's disease (AD), but safety warnings abound. Escitalopram was investigated...
RATIONALE: Escitalopram is a widely used antidepressant for the treatment of patients with major depression. It is the pure S-enantiomer of racemic citalopram. Several clinical trials and meta-analyse...